Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Dec;14(10):1128-34.

[Criteria for the development of a formulary of drugs in a basic health area and impact on prescription]

[Article in Spanish]
M T Pérez Rodríguez  1 , A Catalán Ramos, N Parellada Esquius
Affiliations
  • PMID: 7849214

[Criteria for the development of a formulary of drugs in a basic health area and impact on prescription]

[Article in Spanish]
M T Pérez Rodríguez et al. Aten Primaria. 1994 Dec.

Erratum in

  • Aten Primaria 1995 Mar 15;15(4):270

Abstract

Objective: To promote rational prescription in Primary Care by elaborating a restricted list of medicines in a PC, the implementation of the list and the evaluation of its influence.

Design: Controlled intervention study.

Setting: Intervention group: Castelldefels Health Centre.

Control group: Molí Nou HC in same health sector.

Participants: Doctors from the PC teams of both centres.

Interventions: Initially the prescription for 1992 of the intervention group was analysed. The main therapeutic groups prescribed for on the initiative of the General Practitioners (GP) of the Castelldefels HC were identified and the intervention was then carried out on them. The PC team from the intervention group, chose the drugs by consensus, on the basis of pharmaceutical advice.

Measurements and main results: Castelldefels HD presented worse indicators than the rest of the Sector's. It was observed that the GPs decided 63.4% +/- 3.9% of their therapeutic prescriptions. The groups most prescribed for on GP initiative were systemic (J) and respiratory apparatus (R) anti-infection therapies. The intervention was verified with Macrolids, Beta-lactamics (excluding Cephalosporins) and Quinolones. In neither of the two HDs were statistically significant differences (p < 0.05) in the consumption of the selected antibiotics between the two periods observed.

Conclusions: This process is aimed at altering GPs' attitudes, it is essential that they participate in the choice of medicines in order to keep them involved; and that the ongoing records of the chosen drugs are verified, with the evaluation of their influence then being just one more tool in this process.

PubMed Disclaimer